Notícias

Hartford trades at $145.37 and has moved in lockstep with the market. Its shares have returned 7.6% over the last six months while the S&P 500 has gained 7.1%.

HA Sustainable Infrastructure Capital trades at $37.80 and has moved in lockstep with the market. Its shares have returned 9.8% over the last six months while the S&P 500 has gained 7.1%.

In bull and bear markets, or robust and adverse economic backdrops, this business maintains its commitment to shareholders.

Investors looking for reliable income should examine these boring high-yield stocks to lock in attractive yields in a low-yield market.

Fed Chair Kevin Warsh and the Federal Open Market Committee (FOMC) are contending with elevated inflation, thanks in part to the president's policies.

The stock market bounced but hasn't taken this step while a key risk is growing. SpaceX, AMD, Sandisk, Eli Lilly earnings loom.

Since January 2026, Figs has been in a holding pattern, posting a small loss of 0.5% while floating around $10.75. The stock also fell short of the S&P 500’s 7.1% gain during that period.

Bristol Myers Squibb's P/E ratio is below the industry average, but you have to take this key fact into consideration before buying it.

What triggered the latest focus on Ralph Lauren stock Ralph Lauren (RL) is back in focus after its stock outpaced the S&P 500 with a 2.72% gain on a recent trading day, ahead of an earnings release scheduled for August 6, 2026. This price move comes as the company prepares to report quarterly results that are expected to show higher earnings and revenue compared with the prior year, while analyst consensus on earnings has seen slight downward revisions. See our latest analysis for Ralph...

CRISPR Therapeutics Stock Reaction To Recent Trading Session CRISPR Therapeutics (NasdaqGM:CRSP) recently finished a trading session with a positive price move that outpaced the S&P 500. The stock is drawing attention as investors look ahead to its upcoming earnings report. See our latest analysis for CRISPR Therapeutics. At a share price of US$47.99, CRISPR Therapeutics has seen short term momentum cool, with a 30 day share price return down 13.72% and a 1 year total shareholder return down...

The space stock's three-year return laps the market many times over. What the pullback changed deserves just as much attention.

Ares Capital pays a lot of passive income.

The legendary investor has beaten the market by a wide margin, but he doesn't think you need to.

The S&P 500 has frequently dropped into correction territory during August in midterm election years.

Over the past six months, NVR’s shares (currently trading at $6,296) have posted a disappointing 18.4% loss, well below the S&P 500’s 4.9% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

The prevailing market dynamics serve as a strong tailwind for this tech stock.

W. R. Berkley trades at $73.39 and has moved in lockstep with the market. Its shares have returned 8.3% over the last six months while the S&P 500 has gained 4.9%.

Spectrum Brands’s 35.3% return over the past six months has outpaced the S&P 500 by 30.4%, and its stock price has climbed to $88.80 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

President Donald Trump's policies are affecting more than just fuel prices.

Software is rapidly reducing operating expenses for businesses. This secular theme has materialized in superior earnings growth and stock price performance for most SaaS companies, and over the last six months, the industry’s 13.5% return has topped the S&P 500 by 8.6 percentage points.

The president isn't helping ensure his prediction about the stock market comes true.

Investors are getting nervous, but Warren Buffett has some encouraging advice.

Amazon's performance has taken a step back, but Thursday's report could herald a new era.

SPYI's 12% monthly yield looks like income until you examine what it's actually made of. Three compounding costs hide inside a single headline number, and the fund's own factsheet never adds them up.

Software is rapidly reducing operating expenses for businesses. Companies bringing it to life have been rewarded with explosive earnings growth, and the upward trend shows no signs of stopping as the industry has posted a 13.5% gain over the past six months, beating the S&P 500 by 8.6 percentage points.

Insurance ETFs are garnering attention as a defensive play as investors look to hedge against tech and AI.

Strong tech earnings pushed the Nasdaq to a two-day gain of 3.8%. The S&P 500 finishes flat in July.

Companies that have reported in the Q2 cycle are offering encouraging reads on order trends, margin resilience, and full-year demand. This fundamental health is filtering directly into analyst models, driving a steady stream of upward revisions for Q3 and beyond.

Two of the world’s most important shipping lanes have been gummed-up by the Iran War. The canal is poised to reduce its capacity because of the onset of El Niño, a weather pattern that can cause severe droughts and other extreme weather events in various parts of the world. The canal authority has warned clients that the chances of a severe El Niño system had risen to 81% from 25%.

There's nothing like the combination of a bottom-line beat and a guidance raise.